MedPath

Effect of electro-acupuncture on uterine blood flow characteristics in patients with recurrent implantation failure

Phase 1
Conditions
recurrent implantation failure
Registration Number
ITMCTR2200005690
Lead Sponsor
Chengdu Xinan Gynecological Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged between 22 to 40 female.
(2) Meeting the diagnostic criteria for recurrent implantation failure.
(3) The availability of frozen embryos and prepare for FET .
(4) Patients undergoing endometrial preparation using a hormone replacement therapy or Gnrh-a down regulation hormone replacement therapy.
(5)Patients with endometrial flow type II or type I.
(6) Signed an informed consent form.
Note: Patients meeting all 6 criteria above were included in this study.

Exclusion Criteria

(1) Ultrasound examination shows unaddressed uterine malformations that clearly affect uterine morphology, uterine fibroids that compress the uterine cavity, or ovarian cysts
(2) Having a clearly diagnosis autoimmune disease or pre-thrombotic state, such as systemic lupus erythematosus, rheumatoid arthritis, etc.
(3) Having an unsolved endocrine disorder, such as hyperthyroidism, diabetes mellitus, hypertension, etc.
(4) Suffering from a clearly diagnosed medical or surgical serious primary or secondary disease or psychiatric disorder in progress.
(5) Patients with chromosomal abnormalities(Except for chromosome polymorphism).
(6) The patient has a history of assisted reproduction live births
(7) Patients with bleeding tendencies and those prone to infection, or those suffering from severe allergies, or with skin ulcers or scarring that prohibit needling or dizziness.
(8) Patients who have received acupuncture treatment in the last three months.
(9) Patients who are participating in other clinical trials.
Note: Anyone who meets any 1 of the above criteria will be excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath